Track topics on Twitter Track topics that are important to you
LAS VEGAS, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Allegiant Travel Company (NASDAQ:ALGT) today reported preliminary passenger traffic results for July 2015.
|July 2015||July 2014||Change|
|Revenue passenger miles (000)||970,786||796,634||21.9||%|
|Available seat miles (000)||1,073,453||861,267||24.6||%|
|Load factor||90.4||%||92.5||%||(2.1) pts|
|Average stage length (miles)||897||926||(3.1||)%|
|July 2015||July 2014||Change|
|Revenue passenger miles (000)||979,055||800,551||22.3||%|
|Available seat miles (000)||1,091,750||873,990||24.9||%|
|Load factor||89.7||%||91.6||%||(1.9) pts|
|Average stage length (miles)||885||916||(3.4||)%|
*Total system includes scheduled service and fixed fee contract.
|Preliminary Financial Results|
|June 2015 actual year-over-year|
|Scheduled total revenue per scheduled ASM (TRASM) change||(6.2||%)|
|July 2015 estimated year-over-year TRASM change||(6.5%) to (6.1%)|
|$ per gallon|
|July 2015 estimated average fuel cost per gallon – system||$||1.94|
|July 2015 estimated average fuel cost per gallon – scheduled||$||1.95|
|Capacity guidance, subject to revision||Year over Year Growth|
|3nd Quarter 2015|
|System||+23 to 27%||+21 to 25%|
|Scheduled||+23 to 27%||+21 to 25%|
|4th Quarter 2015|
|System||+21 to 26%||+21 to 26%|
|Scheduled||+21 to 26%||+21 to 26%|
ASMs – Available seat miles
Allegiant, Travel is our deal.®
Las Vegas-based Allegiant Travel Company (NASDAQ:ALGT) is focused on linking travelers in small cities to world-class leisure destinations. The company operates a low-cost, high-efficiency, all-jet passenger airline through its subsidiary, Allegiant Air, while also offering other travel-related products such as hotel rooms, rental cars, and attraction tickets. All can be purchased through the company website, allegiant.com. The company has been named one of America’s 100 Best Small Companies by Forbes Magazine for four consecutive years. For downloadable press kit, including photos, visit: http://gofly.us/SQmY7O.
Note: This news release was accurate at the date of issuance. However, information contained in the release may have changed. If you plan to use the information contained herein for any purpose, verification of its continued accuracy is your responsibility.
For further information please visit the company’s investor website: http://ir.allegiantair.com/
Reference to the Company's website above does not constitute incorporation of any of the information thereon into this news release.
Under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, statements in this press release that are not historical facts are forward-looking statements. These forward-looking statements are only estimates or predictions based on our management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include our statements regarding future departure and capacity growth. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “guidance”,"believe," "expect," "anticipate," "intend," "plan," "estimate,” “project,” “hope” or similar expressions.
Forward-looking statements involve risks, uncertainties and assumptions. Actual results may differ materially from those expressed in the forward-looking statements. Important risk factors that could cause our results to differ materially from those expressed in the forward-looking statements generally may be found in our periodic reports filed with the Securities and Exchange Commission at www.sec.gov.
Any forward-looking statements are based on information available to us today and we undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise.
Allegiant Media Contact: e-mail: firstname.lastname@example.org Investor Inquiries: Chris Allen e-mail:email@example.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...